Analysts/Institutional Investor Meet/Con. Call Updates

August 03, 2026 To, To, Listing Operation Department Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra Kurla Dalal Street, Mumbai-400001 Complex, Bandra (East), Mumbai-400051 (Scrip Code: 544644) (SYMBOL: CORONA) Dear Sir / Madam, Sub.: Audio Recording – Q1 FY27 Earnings Conference Call (i.e. post earnings / quarterly call) In continuation to our letter dated July 22, 2026 and pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of earnings conference call (i.e. post earnings / quarterly call) with Analysts / Investors on Unaudited Financial Results of the Company for the first quarter and three months ended June 30, 2026, is available on the website of the Company at: https://www.coronaremedies.com/q1-fy27-epcar You are requested to take note of the above. Thanking you. Yours faithfully, For CORONA Remedies Limited Chetna Dharajiya Company Secretary and Compliance Officer